Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+26.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+26.5%/yr
Quarterly compound
Percentile
P93
Near historical high
vs 3Y Ago
2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 27.78% |
| Q3 2025 | -12.41% |
| Q2 2025 | 24.52% |
| Q1 2025 | -26.51% |
| Q4 2024 | 22.93% |
| Q3 2024 | -14.05% |
| Q2 2024 | -30.82% |
| Q1 2024 | 43.58% |
| Q4 2023 | -18.29% |
| Q3 2023 | -9.91% |
| Q2 2023 | -2.19% |
| Q1 2023 | -17.61% |
| Q4 2022 | 13.71% |
| Q3 2022 | -15.85% |
| Q2 2022 | -16.11% |
| Q1 2022 | -23.84% |
| Q4 2021 | 25.36% |
| Q3 2021 | -89.05% |
| Q2 2021 | -160.33% |
| Q1 2021 | 232.23% |
| Q4 2020 | -46.73% |
| Q3 2020 | -15.33% |
| Q2 2020 | 6.67% |
| Q1 2020 | 1.88% |
| Q4 2019 | -30.04% |
| Q3 2019 | -16.28% |
| Q2 2019 | -39.17% |
| Q1 2019 | 0.00% |